Ovar IMAB027 first-in-human (#543)
Laufzeit: 01.01.2015 - 31.12.2019
imported
Kurzfassung
A first-in-human, accelerated titration, dose escalation phase I/II trial of IMAB027 in patients with advanced CLDN6-positive ovarian cancer
